nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—liver cancer	0.81	1	CbGaD
Glipizide—Gliclazide—VEGFA—liver cancer	0.00202	0.709	CrCbGaD
Glipizide—Haematochezia—Epirubicin—liver cancer	0.00155	0.0201	CcSEcCtD
Glipizide—Haematochezia—Doxorubicin—liver cancer	0.00143	0.0186	CcSEcCtD
Glipizide—Hepatic function abnormal—Sorafenib—liver cancer	0.0014	0.0182	CcSEcCtD
Glipizide—Eczema—Sorafenib—liver cancer	0.00136	0.0177	CcSEcCtD
Glipizide—Hyponatraemia—Sorafenib—liver cancer	0.00123	0.0159	CcSEcCtD
Glipizide—Abdominal pain upper—Sorafenib—liver cancer	0.00112	0.0145	CcSEcCtD
Glipizide—Abdominal discomfort—Sorafenib—liver cancer	0.00102	0.0132	CcSEcCtD
Glipizide—Eruption—Epirubicin—liver cancer	0.00101	0.0131	CcSEcCtD
Glipizide—Eruption—Doxorubicin—liver cancer	0.000938	0.0122	CcSEcCtD
Glipizide—Jaundice—Sorafenib—liver cancer	0.00092	0.0119	CcSEcCtD
Glipizide—Hepatobiliary disease—Sorafenib—liver cancer	0.000893	0.0116	CcSEcCtD
Glipizide—Flushing—Sorafenib—liver cancer	0.000787	0.0102	CcSEcCtD
Glipizide—Arrhythmia—Sorafenib—liver cancer	0.000757	0.00982	CcSEcCtD
Glipizide—Liver injury—Epirubicin—liver cancer	0.000741	0.00961	CcSEcCtD
Glipizide—Erythema—Sorafenib—liver cancer	0.000738	0.00956	CcSEcCtD
Glipizide—Jaundice cholestatic—Epirubicin—liver cancer	0.00071	0.0092	CcSEcCtD
Glipizide—Muscle spasms—Sorafenib—liver cancer	0.000709	0.0092	CcSEcCtD
Glipizide—Liver injury—Doxorubicin—liver cancer	0.000686	0.00889	CcSEcCtD
Glipizide—Syncope—Sorafenib—liver cancer	0.000662	0.00858	CcSEcCtD
Glipizide—Leukopenia—Sorafenib—liver cancer	0.00066	0.00856	CcSEcCtD
Glipizide—Jaundice cholestatic—Doxorubicin—liver cancer	0.000657	0.00852	CcSEcCtD
Glipizide—Loss of consciousness—Sorafenib—liver cancer	0.000648	0.00841	CcSEcCtD
Glipizide—Gait disturbance—Epirubicin—liver cancer	0.000639	0.00829	CcSEcCtD
Glipizide—Hypertension—Sorafenib—liver cancer	0.000637	0.00826	CcSEcCtD
Glipizide—Myalgia—Sorafenib—liver cancer	0.000628	0.00814	CcSEcCtD
Glipizide—Arthralgia—Sorafenib—liver cancer	0.000628	0.00814	CcSEcCtD
Glipizide—Hepatocellular injury—Epirubicin—liver cancer	0.000624	0.00809	CcSEcCtD
Glipizide—Shock—Sorafenib—liver cancer	0.000592	0.00768	CcSEcCtD
Glipizide—Gait disturbance—Doxorubicin—liver cancer	0.000591	0.00767	CcSEcCtD
Glipizide—Thrombocytopenia—Sorafenib—liver cancer	0.00059	0.00764	CcSEcCtD
Glipizide—Aplastic anaemia—Epirubicin—liver cancer	0.000586	0.00759	CcSEcCtD
Glipizide—Hepatocellular injury—Doxorubicin—liver cancer	0.000577	0.00748	CcSEcCtD
Glipizide—Anorexia—Sorafenib—liver cancer	0.000574	0.00744	CcSEcCtD
Glipizide—Cramps of lower extremities—Epirubicin—liver cancer	0.000573	0.00743	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000549	0.00711	CcSEcCtD
Glipizide—Hypertonia—Epirubicin—liver cancer	0.000547	0.00709	CcSEcCtD
Glipizide—Abnormal vision—Epirubicin—liver cancer	0.000544	0.00705	CcSEcCtD
Glipizide—Aplastic anaemia—Doxorubicin—liver cancer	0.000542	0.00702	CcSEcCtD
Glipizide—Gliclazide—ALB—liver cancer	0.000542	0.191	CrCbGaD
Glipizide—Dyspnoea—Sorafenib—liver cancer	0.000537	0.00696	CcSEcCtD
Glipizide—Cramps of lower extremities—Doxorubicin—liver cancer	0.00053	0.00687	CcSEcCtD
Glipizide—Dyspepsia—Sorafenib—liver cancer	0.00053	0.00687	CcSEcCtD
Glipizide—Decreased appetite—Sorafenib—liver cancer	0.000523	0.00679	CcSEcCtD
Glipizide—Gastrointestinal disorder—Sorafenib—liver cancer	0.00052	0.00674	CcSEcCtD
Glipizide—Hepatic function abnormal—Epirubicin—liver cancer	0.000518	0.00672	CcSEcCtD
Glipizide—Constipation—Sorafenib—liver cancer	0.000515	0.00668	CcSEcCtD
Glipizide—Pain—Sorafenib—liver cancer	0.000515	0.00668	CcSEcCtD
Glipizide—Hypertonia—Doxorubicin—liver cancer	0.000506	0.00656	CcSEcCtD
Glipizide—Eczema—Epirubicin—liver cancer	0.000504	0.00653	CcSEcCtD
Glipizide—Abnormal vision—Doxorubicin—liver cancer	0.000503	0.00653	CcSEcCtD
Glipizide—Gastrointestinal pain—Sorafenib—liver cancer	0.000492	0.00638	CcSEcCtD
Glipizide—Hepatic function abnormal—Doxorubicin—liver cancer	0.000479	0.00621	CcSEcCtD
Glipizide—Urticaria—Sorafenib—liver cancer	0.000478	0.0062	CcSEcCtD
Glipizide—Abdominal pain—Sorafenib—liver cancer	0.000476	0.00617	CcSEcCtD
Glipizide—Eczema—Doxorubicin—liver cancer	0.000466	0.00604	CcSEcCtD
Glipizide—Hypoglycaemia—Epirubicin—liver cancer	0.000464	0.00601	CcSEcCtD
Glipizide—Hyponatraemia—Epirubicin—liver cancer	0.000455	0.00589	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000453	0.00587	CcSEcCtD
Glipizide—Diplopia—Epirubicin—liver cancer	0.000453	0.00587	CcSEcCtD
Glipizide—Migraine—Epirubicin—liver cancer	0.000446	0.00578	CcSEcCtD
Glipizide—Hypersensitivity—Sorafenib—liver cancer	0.000444	0.00575	CcSEcCtD
Glipizide—Asthenia—Sorafenib—liver cancer	0.000432	0.0056	CcSEcCtD
Glipizide—Hypoglycaemia—Doxorubicin—liver cancer	0.000429	0.00557	CcSEcCtD
Glipizide—Pruritus—Sorafenib—liver cancer	0.000426	0.00552	CcSEcCtD
Glipizide—Hyponatraemia—Doxorubicin—liver cancer	0.000421	0.00545	CcSEcCtD
Glipizide—Diplopia—Doxorubicin—liver cancer	0.000419	0.00543	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000419	0.00543	CcSEcCtD
Glipizide—Abdominal pain upper—Epirubicin—liver cancer	0.000413	0.00536	CcSEcCtD
Glipizide—Migraine—Doxorubicin—liver cancer	0.000412	0.00535	CcSEcCtD
Glipizide—Diarrhoea—Sorafenib—liver cancer	0.000412	0.00534	CcSEcCtD
Glipizide—Dizziness—Sorafenib—liver cancer	0.000398	0.00516	CcSEcCtD
Glipizide—Vomiting—Sorafenib—liver cancer	0.000383	0.00496	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—liver cancer	0.000383	0.00496	CcSEcCtD
Glipizide—Rash—Sorafenib—liver cancer	0.00038	0.00492	CcSEcCtD
Glipizide—Dermatitis—Sorafenib—liver cancer	0.000379	0.00492	CcSEcCtD
Glipizide—Headache—Sorafenib—liver cancer	0.000377	0.00489	CcSEcCtD
Glipizide—Pancytopenia—Epirubicin—liver cancer	0.000372	0.00482	CcSEcCtD
Glipizide—Dysuria—Epirubicin—liver cancer	0.000366	0.00474	CcSEcCtD
Glipizide—Nausea—Sorafenib—liver cancer	0.000358	0.00464	CcSEcCtD
Glipizide—Photosensitivity reaction—Epirubicin—liver cancer	0.000357	0.00463	CcSEcCtD
Glipizide—Drowsiness—Epirubicin—liver cancer	0.000349	0.00452	CcSEcCtD
Glipizide—Pancytopenia—Doxorubicin—liver cancer	0.000344	0.00446	CcSEcCtD
Glipizide—Jaundice—Epirubicin—liver cancer	0.00034	0.00441	CcSEcCtD
Glipizide—Conjunctivitis—Epirubicin—liver cancer	0.000339	0.0044	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—liver cancer	0.000339	0.00439	CcSEcCtD
Glipizide—Sweating—Epirubicin—liver cancer	0.000334	0.00434	CcSEcCtD
Glipizide—Photosensitivity reaction—Doxorubicin—liver cancer	0.00033	0.00428	CcSEcCtD
Glipizide—Hepatobiliary disease—Epirubicin—liver cancer	0.00033	0.00428	CcSEcCtD
Glipizide—Agranulocytosis—Epirubicin—liver cancer	0.000326	0.00422	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—liver cancer	0.000323	0.00419	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—liver cancer	0.000315	0.00408	CcSEcCtD
Glipizide—Rhinitis—Epirubicin—liver cancer	0.000314	0.00407	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—liver cancer	0.000314	0.00407	CcSEcCtD
Glipizide—Hepatitis—Epirubicin—liver cancer	0.000313	0.00406	CcSEcCtD
Glipizide—Hypoaesthesia—Epirubicin—liver cancer	0.000312	0.00404	CcSEcCtD
Glipizide—Pharyngitis—Epirubicin—liver cancer	0.000311	0.00403	CcSEcCtD
Glipizide—Sweating—Doxorubicin—liver cancer	0.000309	0.00401	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—liver cancer	0.000305	0.00396	CcSEcCtD
Glipizide—Visual impairment—Epirubicin—liver cancer	0.000302	0.00391	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—liver cancer	0.000301	0.00391	CcSEcCtD
Glipizide—Eye disorder—Epirubicin—liver cancer	0.000293	0.00379	CcSEcCtD
Glipizide—Flushing—Epirubicin—liver cancer	0.000291	0.00377	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—liver cancer	0.000291	0.00377	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—liver cancer	0.00029	0.00376	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—liver cancer	0.000288	0.00374	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—liver cancer	0.000288	0.00373	CcSEcCtD
Glipizide—Glyburide—ALB—liver cancer	0.000285	0.1	CrCbGaD
Glipizide—Chills—Epirubicin—liver cancer	0.000281	0.00364	CcSEcCtD
Glipizide—Arrhythmia—Epirubicin—liver cancer	0.00028	0.00363	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—liver cancer	0.000279	0.00362	CcSEcCtD
Glipizide—Erythema—Epirubicin—liver cancer	0.000273	0.00353	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—liver cancer	0.000271	0.00351	CcSEcCtD
Glipizide—Flushing—Doxorubicin—liver cancer	0.000269	0.00349	CcSEcCtD
Glipizide—Flatulence—Epirubicin—liver cancer	0.000269	0.00348	CcSEcCtD
Glipizide—Tension—Epirubicin—liver cancer	0.000268	0.00347	CcSEcCtD
Glipizide—Nervousness—Epirubicin—liver cancer	0.000265	0.00343	CcSEcCtD
Glipizide—Muscle spasms—Epirubicin—liver cancer	0.000262	0.0034	CcSEcCtD
Glipizide—Chills—Doxorubicin—liver cancer	0.00026	0.00337	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—liver cancer	0.000259	0.00336	CcSEcCtD
Glipizide—Vision blurred—Epirubicin—liver cancer	0.000257	0.00333	CcSEcCtD
Glipizide—Ill-defined disorder—Epirubicin—liver cancer	0.000253	0.00328	CcSEcCtD
Glipizide—Erythema—Doxorubicin—liver cancer	0.000252	0.00327	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—liver cancer	0.000249	0.00322	CcSEcCtD
Glipizide—Tension—Doxorubicin—liver cancer	0.000248	0.00321	CcSEcCtD
Glipizide—Malaise—Epirubicin—liver cancer	0.000246	0.00319	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—liver cancer	0.000245	0.00318	CcSEcCtD
Glipizide—Vertigo—Epirubicin—liver cancer	0.000245	0.00318	CcSEcCtD
Glipizide—Syncope—Epirubicin—liver cancer	0.000245	0.00317	CcSEcCtD
Glipizide—Leukopenia—Epirubicin—liver cancer	0.000244	0.00316	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—liver cancer	0.000243	0.00314	CcSEcCtD
Glipizide—Loss of consciousness—Epirubicin—liver cancer	0.00024	0.00311	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—liver cancer	0.000238	0.00308	CcSEcCtD
Glipizide—Hypertension—Epirubicin—liver cancer	0.000235	0.00305	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—liver cancer	0.000234	0.00303	CcSEcCtD
Glipizide—Arthralgia—Epirubicin—liver cancer	0.000232	0.00301	CcSEcCtD
Glipizide—Myalgia—Epirubicin—liver cancer	0.000232	0.00301	CcSEcCtD
Glipizide—Anxiety—Epirubicin—liver cancer	0.000231	0.003	CcSEcCtD
Glipizide—Discomfort—Epirubicin—liver cancer	0.000229	0.00297	CcSEcCtD
Glipizide—Malaise—Doxorubicin—liver cancer	0.000227	0.00295	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—liver cancer	0.000227	0.00294	CcSEcCtD
Glipizide—Syncope—Doxorubicin—liver cancer	0.000226	0.00293	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—liver cancer	0.000226	0.00293	CcSEcCtD
Glipizide—Confusional state—Epirubicin—liver cancer	0.000224	0.00291	CcSEcCtD
Glipizide—Oedema—Epirubicin—liver cancer	0.000223	0.00288	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—liver cancer	0.000222	0.00287	CcSEcCtD
Glipizide—Shock—Epirubicin—liver cancer	0.000219	0.00284	CcSEcCtD
Glipizide—Thrombocytopenia—Epirubicin—liver cancer	0.000218	0.00282	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—liver cancer	0.000218	0.00282	CcSEcCtD
Glipizide—Hyperhidrosis—Epirubicin—liver cancer	0.000215	0.00279	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—liver cancer	0.000215	0.00278	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—liver cancer	0.000215	0.00278	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—liver cancer	0.000214	0.00277	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—liver cancer	0.000212	0.00275	CcSEcCtD
Glipizide—Anorexia—Epirubicin—liver cancer	0.000212	0.00275	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—liver cancer	0.000208	0.00269	CcSEcCtD
Glipizide—Oedema—Doxorubicin—liver cancer	0.000206	0.00267	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000203	0.00263	CcSEcCtD
Glipizide—Shock—Doxorubicin—liver cancer	0.000203	0.00263	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—liver cancer	0.000202	0.00261	CcSEcCtD
Glipizide—Insomnia—Epirubicin—liver cancer	0.000201	0.00261	CcSEcCtD
Glipizide—Paraesthesia—Epirubicin—liver cancer	0.0002	0.00259	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—liver cancer	0.000199	0.00258	CcSEcCtD
Glipizide—Dyspnoea—Epirubicin—liver cancer	0.000198	0.00257	CcSEcCtD
Glipizide—Somnolence—Epirubicin—liver cancer	0.000198	0.00256	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—liver cancer	0.000196	0.00254	CcSEcCtD
Glipizide—Dyspepsia—Epirubicin—liver cancer	0.000196	0.00254	CcSEcCtD
Glipizide—Decreased appetite—Epirubicin—liver cancer	0.000193	0.00251	CcSEcCtD
Glipizide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000192	0.00249	CcSEcCtD
Glipizide—Pain—Epirubicin—liver cancer	0.00019	0.00247	CcSEcCtD
Glipizide—Constipation—Epirubicin—liver cancer	0.00019	0.00247	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000188	0.00243	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—liver cancer	0.000186	0.00241	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—liver cancer	0.000185	0.0024	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—liver cancer	0.000184	0.00238	CcSEcCtD
Glipizide—Feeling abnormal—Epirubicin—liver cancer	0.000183	0.00238	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—liver cancer	0.000183	0.00237	CcSEcCtD
Glipizide—Gastrointestinal pain—Epirubicin—liver cancer	0.000182	0.00236	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—liver cancer	0.000181	0.00235	CcSEcCtD
Glipizide—Decreased appetite—Doxorubicin—liver cancer	0.000179	0.00232	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000178	0.0023	CcSEcCtD
Glipizide—Urticaria—Epirubicin—liver cancer	0.000177	0.00229	CcSEcCtD
Glipizide—Pain—Doxorubicin—liver cancer	0.000176	0.00228	CcSEcCtD
Glipizide—Constipation—Doxorubicin—liver cancer	0.000176	0.00228	CcSEcCtD
Glipizide—Abdominal pain—Epirubicin—liver cancer	0.000176	0.00228	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—liver cancer	0.00017	0.0022	CcSEcCtD
Glipizide—Gastrointestinal pain—Doxorubicin—liver cancer	0.000168	0.00218	CcSEcCtD
Glipizide—Hypersensitivity—Epirubicin—liver cancer	0.000164	0.00213	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—liver cancer	0.000164	0.00212	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—liver cancer	0.000163	0.00211	CcSEcCtD
Glipizide—Asthenia—Epirubicin—liver cancer	0.00016	0.00207	CcSEcCtD
Glipizide—Pruritus—Epirubicin—liver cancer	0.000157	0.00204	CcSEcCtD
Glipizide—Diarrhoea—Epirubicin—liver cancer	0.000152	0.00197	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—liver cancer	0.000152	0.00197	CcSEcCtD
Glipizide—Asthenia—Doxorubicin—liver cancer	0.000148	0.00192	CcSEcCtD
Glipizide—Dizziness—Epirubicin—liver cancer	0.000147	0.00191	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—liver cancer	0.000146	0.00189	CcSEcCtD
Glipizide—Vomiting—Epirubicin—liver cancer	0.000141	0.00183	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—liver cancer	0.000141	0.00183	CcSEcCtD
Glipizide—Rash—Epirubicin—liver cancer	0.00014	0.00182	CcSEcCtD
Glipizide—Dermatitis—Epirubicin—liver cancer	0.00014	0.00182	CcSEcCtD
Glipizide—Headache—Epirubicin—liver cancer	0.000139	0.00181	CcSEcCtD
Glipizide—Dizziness—Doxorubicin—liver cancer	0.000136	0.00177	CcSEcCtD
Glipizide—Nausea—Epirubicin—liver cancer	0.000132	0.00171	CcSEcCtD
Glipizide—Vomiting—Doxorubicin—liver cancer	0.000131	0.0017	CcSEcCtD
Glipizide—Rash—Doxorubicin—liver cancer	0.00013	0.00168	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—liver cancer	0.00013	0.00168	CcSEcCtD
Glipizide—Headache—Doxorubicin—liver cancer	0.000129	0.00167	CcSEcCtD
Glipizide—Nausea—Doxorubicin—liver cancer	0.000122	0.00159	CcSEcCtD
Glipizide—PPARG—Adipogenesis—STAT3—liver cancer	0.000109	0.00099	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000108	0.000984	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—RAF1—liver cancer	0.000106	0.000964	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000106	0.000963	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR1H4—liver cancer	0.000105	0.000959	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000105	0.000952	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000104	0.00095	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR1I3—liver cancer	0.000104	0.000943	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000103	0.000939	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTA4—liver cancer	0.000103	0.000936	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000102	0.000928	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TGFB1—liver cancer	0.000101	0.000918	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTA2—liver cancer	0.0001	0.000912	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTA4—liver cancer	9.98e-05	0.000907	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTA1—liver cancer	9.85e-05	0.000895	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—NAT2—liver cancer	9.74e-05	0.000885	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTA2—liver cancer	9.72e-05	0.000884	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTA1—liver cancer	9.67e-05	0.00088	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP2E1—liver cancer	9.62e-05	0.000875	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	9.6e-05	0.000873	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NAT2—liver cancer	9.57e-05	0.00087	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	9.49e-05	0.000863	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—liver cancer	9.43e-05	0.000857	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTA1—liver cancer	9.38e-05	0.000853	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NAT2—liver cancer	9.28e-05	0.000843	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9.21e-05	0.000838	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALDOB—liver cancer	9.17e-05	0.000834	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ABL1—liver cancer	9.05e-05	0.000823	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALDOB—liver cancer	8.89e-05	0.000809	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—JUN—liver cancer	8.88e-05	0.000808	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GGT1—liver cancer	8.83e-05	0.000803	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CRABP1—liver cancer	8.75e-05	0.000796	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—PPARA—liver cancer	8.75e-05	0.000795	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	8.58e-05	0.00078	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CPT1B—liver cancer	8.51e-05	0.000773	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GLUL—liver cancer	8.51e-05	0.000773	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CRABP1—liver cancer	8.48e-05	0.000771	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—MAPK8—liver cancer	8.41e-05	0.000764	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NR1H4—liver cancer	8.2e-05	0.000746	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	8.16e-05	0.000742	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTA3—liver cancer	8.06e-05	0.000733	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTP1—liver cancer	7.93e-05	0.000721	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—PPARA—liver cancer	7.84e-05	0.000713	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	7.83e-05	0.000712	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—HPGDS—liver cancer	7.78e-05	0.000708	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HPGDS—liver cancer	7.65e-05	0.000695	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—IL6—liver cancer	7.61e-05	0.000692	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HPGDS—liver cancer	7.42e-05	0.000674	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—PPARA—liver cancer	7.38e-05	0.000671	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTA4—liver cancer	7.37e-05	0.000671	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTM1—liver cancer	7.29e-05	0.000663	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.21e-05	0.000655	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	7.19e-05	0.000654	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HNF4A—liver cancer	7.19e-05	0.000654	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTA2—liver cancer	7.19e-05	0.000653	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—ESR1—liver cancer	7.1e-05	0.000646	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.03e-05	0.000639	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTA1—liver cancer	6.93e-05	0.00063	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP1A1—liver cancer	6.91e-05	0.000629	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KDR—liver cancer	6.86e-05	0.000624	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NAT2—liver cancer	6.86e-05	0.000623	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	6.82e-05	0.00062	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK14—liver cancer	6.82e-05	0.00062	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PSMD10—liver cancer	6.82e-05	0.00062	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PSMA4—liver cancer	6.82e-05	0.00062	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	6.78e-05	0.000617	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MET—liver cancer	6.72e-05	0.000611	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GOT2—liver cancer	6.63e-05	0.000603	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PSMA4—liver cancer	6.61e-05	0.000601	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PSMD10—liver cancer	6.61e-05	0.000601	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.59e-05	0.000599	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALDOB—liver cancer	6.57e-05	0.000598	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ALB—liver cancer	6.5e-05	0.000591	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GOT2—liver cancer	6.43e-05	0.000585	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP2E1—liver cancer	6.35e-05	0.000577	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PSMA4—liver cancer	6.28e-05	0.000571	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PSMD10—liver cancer	6.28e-05	0.000571	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CRABP1—liver cancer	6.27e-05	0.00057	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	6.26e-05	0.000569	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP2E1—liver cancer	6.23e-05	0.000567	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP2E1—liver cancer	6.05e-05	0.00055	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—HRAS—liver cancer	6.02e-05	0.000547	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—RAF1—liver cancer	5.88e-05	0.000535	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—liver cancer	5.86e-05	0.000533	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—SERPINE1—liver cancer	5.84e-05	0.000531	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—HRAS—liver cancer	5.84e-05	0.000531	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYCS—liver cancer	5.83e-05	0.00053	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GGT1—liver cancer	5.83e-05	0.00053	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GGT1—liver cancer	5.72e-05	0.00052	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GOT1—liver cancer	5.72e-05	0.00052	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYCS—liver cancer	5.66e-05	0.000514	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.65e-05	0.000513	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP2—liver cancer	5.6e-05	0.000509	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GGT1—liver cancer	5.55e-05	0.000505	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GOT1—liver cancer	5.55e-05	0.000505	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HPGDS—liver cancer	5.48e-05	0.000498	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—IL6—liver cancer	5.37e-05	0.000488	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.23e-05	0.000476	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.18e-05	0.000471	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UGDH—liver cancer	5.17e-05	0.00047	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.16e-05	0.000469	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTP1—liver cancer	5.14e-05	0.000467	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HMOX1—liver cancer	5.07e-05	0.000461	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTP1—liver cancer	4.99e-05	0.000453	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.96e-05	0.000451	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RAF1—liver cancer	4.96e-05	0.000451	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HMOX1—liver cancer	4.92e-05	0.000447	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.9e-05	0.000445	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PSMA4—liver cancer	4.88e-05	0.000444	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PSMD10—liver cancer	4.88e-05	0.000444	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—EPT1—liver cancer	4.86e-05	0.000442	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.81e-05	0.000437	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GOT2—liver cancer	4.75e-05	0.000432	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.74e-05	0.000431	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTM1—liver cancer	4.72e-05	0.00043	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TAT—liver cancer	4.61e-05	0.000419	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTM1—liver cancer	4.58e-05	0.000417	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.56e-05	0.000415	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.53e-05	0.000412	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.5e-05	0.000409	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP1A1—liver cancer	4.48e-05	0.000407	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2E1—liver cancer	4.47e-05	0.000406	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP1A1—liver cancer	4.34e-05	0.000395	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.33e-05	0.000393	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CTNNB1—liver cancer	4.29e-05	0.00039	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—H2AFX—liver cancer	4.24e-05	0.000386	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—liver cancer	4.21e-05	0.000383	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYCS—liver cancer	4.18e-05	0.00038	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MTHFR—liver cancer	4.18e-05	0.00038	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GGT1—liver cancer	4.1e-05	0.000373	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GOT1—liver cancer	4.1e-05	0.000373	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARA—liver cancer	4.1e-05	0.000372	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MTHFR—liver cancer	4.05e-05	0.000368	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARA—liver cancer	3.97e-05	0.000361	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—liver cancer	3.78e-05	0.000344	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PPARA—liver cancer	3.78e-05	0.000343	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—STAT3—liver cancer	3.74e-05	0.00034	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—liver cancer	3.7e-05	0.000336	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—liver cancer	3.68e-05	0.000335	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—liver cancer	3.63e-05	0.00033	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CG—liver cancer	3.51e-05	0.000319	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK14—liver cancer	3.49e-05	0.000317	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—liver cancer	3.47e-05	0.000316	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR1—liver cancer	3.42e-05	0.000311	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UGDH—liver cancer	3.41e-05	0.00031	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CG—liver cancer	3.4e-05	0.000309	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.39e-05	0.000308	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PPARG—liver cancer	3.39e-05	0.000308	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—liver cancer	3.39e-05	0.000308	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PPARG—liver cancer	3.28e-05	0.000299	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—liver cancer	3.24e-05	0.000295	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KRAS—liver cancer	3.21e-05	0.000292	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1A1—liver cancer	3.21e-05	0.000292	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—EPT1—liver cancer	3.21e-05	0.000291	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CPT1B—liver cancer	3.13e-05	0.000285	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GLUL—liver cancer	3.13e-05	0.000285	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CD—liver cancer	3.08e-05	0.00028	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—liver cancer	3.04e-05	0.000277	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TAT—liver cancer	3.04e-05	0.000276	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NR1H4—liver cancer	3.02e-05	0.000275	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—liver cancer	2.99e-05	0.000272	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CD—liver cancer	2.99e-05	0.000272	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA3—liver cancer	2.97e-05	0.00027	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—liver cancer	2.95e-05	0.000268	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPARA—liver cancer	2.94e-05	0.000267	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SERPINE1—liver cancer	2.81e-05	0.000256	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HRAS—liver cancer	2.73e-05	0.000248	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA4—liver cancer	2.72e-05	0.000247	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CB—liver cancer	2.69e-05	0.000244	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.65e-05	0.000241	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA2—liver cancer	2.65e-05	0.000241	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.64e-05	0.00024	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—liver cancer	2.61e-05	0.000238	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CB—liver cancer	2.61e-05	0.000237	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA1—liver cancer	2.55e-05	0.000232	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NAT2—liver cancer	2.52e-05	0.00023	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CG—liver cancer	2.51e-05	0.000229	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.43e-05	0.000221	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDOB—liver cancer	2.42e-05	0.00022	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—liver cancer	2.41e-05	0.000219	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CRABP1—liver cancer	2.31e-05	0.00021	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CD—liver cancer	2.21e-05	0.000201	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—liver cancer	2.18e-05	0.000198	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.08e-05	0.000189	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GLUL—liver cancer	2.07e-05	0.000188	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CPT1B—liver cancer	2.07e-05	0.000188	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HPGDS—liver cancer	2.02e-05	0.000184	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.01e-05	0.000182	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NR1H4—liver cancer	1.99e-05	0.000181	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA3—liver cancer	1.96e-05	0.000178	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CB—liver cancer	1.93e-05	0.000175	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.83e-05	0.000166	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.8e-05	0.000164	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PSMA4—liver cancer	1.8e-05	0.000164	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PSMD10—liver cancer	1.8e-05	0.000164	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA4—liver cancer	1.79e-05	0.000163	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—liver cancer	1.78e-05	0.000162	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GOT2—liver cancer	1.75e-05	0.000159	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA2—liver cancer	1.75e-05	0.000159	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA1—liver cancer	1.68e-05	0.000153	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NAT2—liver cancer	1.67e-05	0.000151	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2E1—liver cancer	1.65e-05	0.00015	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—liver cancer	1.64e-05	0.000149	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDOB—liver cancer	1.6e-05	0.000145	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.59e-05	0.000145	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—liver cancer	1.59e-05	0.000144	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYCS—liver cancer	1.54e-05	0.00014	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CRABP1—liver cancer	1.52e-05	0.000138	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GGT1—liver cancer	1.51e-05	0.000137	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GOT1—liver cancer	1.51e-05	0.000137	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—liver cancer	1.36e-05	0.000123	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—liver cancer	1.34e-05	0.000122	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—liver cancer	1.34e-05	0.000122	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HPGDS—liver cancer	1.33e-05	0.000121	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—liver cancer	1.3e-05	0.000118	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—liver cancer	1.25e-05	0.000113	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—liver cancer	1.23e-05	0.000112	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PSMA4—liver cancer	1.19e-05	0.000108	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PSMD10—liver cancer	1.19e-05	0.000108	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1A1—liver cancer	1.18e-05	0.000107	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—liver cancer	1.17e-05	0.000107	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GOT2—liver cancer	1.15e-05	0.000105	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—liver cancer	1.1e-05	0.0001	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2E1—liver cancer	1.09e-05	9.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARA—liver cancer	1.08e-05	9.83e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYCS—liver cancer	1.02e-05	9.23e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GGT1—liver cancer	9.96e-06	9.06e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GOT1—liver cancer	9.96e-06	9.06e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.71e-06	8.83e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—liver cancer	9.59e-06	8.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CG—liver cancer	9.26e-06	8.42e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—liver cancer	8.95e-06	8.14e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—liver cancer	8.94e-06	8.13e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—liver cancer	8.83e-06	8.02e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—liver cancer	8.22e-06	7.48e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CD—liver cancer	8.14e-06	7.4e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—liver cancer	8.04e-06	7.31e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1A1—liver cancer	7.8e-06	7.09e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—liver cancer	7.27e-06	6.61e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARA—liver cancer	7.13e-06	6.48e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CB—liver cancer	7.09e-06	6.45e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CG—liver cancer	6.11e-06	5.55e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—liver cancer	5.89e-06	5.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CD—liver cancer	5.37e-06	4.88e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—liver cancer	5.3e-06	4.82e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CB—liver cancer	4.68e-06	4.25e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—liver cancer	4.32e-06	3.93e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—liver cancer	3.53e-06	3.21e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—liver cancer	2.85e-06	2.59e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—liver cancer	2.33e-06	2.12e-05	CbGpPWpGaD
